NSE › Healthcare

AstraZeneca Pharma India Limited (ASTRAZEN)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹8,300.00+2.47%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹579 cr
Revenue YoY
+21.2%
Net profit
₹45 cr
Profit YoY
-23.0%
EPS
₹10.54
EPS estimate
₹7.77
Net margin
7.8%

EPS came in at 10.54 against a street estimate of 7.77 — a beat of 35.6%.

Key statistics

Market cap
₹20,250 cr
P/E
107.5
Forward P/E
102.0
P/B
23.20
Book value
₹349.12
EPS (TTM)
₹75.33
Dividend yield
0.44%
52-week high
₹9,805.69
52-week low
₹7,517.91
50-day MA
₹8,327.91
200-day MA
₹8,601.76
Beta
0.26

Shareholding

Promoters
81.58%
Institutions
7.83%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for AstraZeneca Pharma India Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.